2021 Behavioral Neurology & Neuropsychiatry Reading List, Learning Objectives, and CME

Reading List

Please click below to access the 2021 Behavioral Neurology & Neuropsychiatry reading list.

2021 Behavioral Neurology & Neuropsychiatry Reading List »

C-cert Activity Description

The Continuous Certification (C-cert) activities provide subspecialty learning and knowledge assessment to ensure that diplomates are staying up to date on the latest science, treatments, and therapeutics relating to their subspecialty. The annual activities include: 1) reading the subspecialty  journal articles, and 2) taking and passing the 25-question online post-reading quiz to assess knowledge gained from the journal article content. 

Learning Objectives

Upon completion of this UCNS C-cert activity, participants will be able to:
  • Diagnose the varying dementias earlier in their course and indicate the evidence-based treatments available to treat behavioral symptoms that can emerge in dementias
  • More accurately diagnose neuropsychiatric illnesses that have symptoms that are common to more than one condition and therefore be able to provide more timely and accurate treatments earlier in illness course

Core Competencies

This UCNS C-cert activity covers the following core competency:
  • Medical Knowledge

Continuing Medical Education (CME) Instructions

To claim CME credits, answer question 26 on the quiz to reflect the total time spent completing the required reading and online quiz. This question is not included in the scoring of the quiz. A passing score of 80% of higher is needed to meet C-cert requirements and receive CME credit. CME credit confirmation will be emailed within three weeks of passing the quiz.

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Neurology Institute (AANI) and United Council for Neurologic Subspecialties. The AANI is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Academy of Neurology Institute designates this enduring material for a maximum of 11 AMA PRA Category 1TM credit(s). Physicians should claim only their credit commensurate with the extent of the participation in the activity.

ABPN Self-Assessment Designation Statement

The American Board of Psychiatry & Neurology (ABPN) has reviewed the UCNS Continuous Certification (C-cert) self-assessment activity and has approved the program as a part of a comprehensive self-assessment (SA) program, which is mandates by the American Board of Medical Specialties as a necessary component of maintenance of certification. The number of ABPN SA credits granted will equal the number of CME hours claimed for the activity. 


The UCNS complies with all standards and policies of the ACCME, including identification and resolution of all conflicts of interest prior to the educational activity being delivered to learners. Accordingly, UCNS  planners, authors, and staff comply with the UCNS’s Conflicts of Interest Policy

2021 C-cert Activity Planner Disclosures
All relevant financial relationships have been mitigated.

Behavioral Neurology & Neuropsychiatry Certification Examination Committee Contributors

Robin A. Hurley, MD, FANPA, W.G. Hefner VA Medical Center
Disclosures: Employee of the Veterans Administration (VA). VA received research funding from Teva Pharma for posttraumatic migraine study, Aptinyx, Inc for PTSD and sleep study, and Avanir Pharmaceuticals for traumatic brain injury and aggression study. Role: Principal investigator. VA received research funding for the million veteran program, the MIRECC, relating to PTSD and TBI, funding for a genetics study called PRIME, and funding for a study of suvorexant for PTSD-related insomnia. No personal compensation received related to the research funding received.

James R. Bateman, III, MD, Wake Forest School of Medicine
Disclosures: Nothing to disclose.

Donald P. Eknoyan, MD, Kaiser Permanente
Disclosures: Nothing to disclose.

Kyle J. Steinman, MD, MAS, University of Washington/Seattle Children's Hospital
Disclosures: Received research funding from a government organization.

Colin J. Harrington, MD, Rhode Island Hospital and Brown University Medical School
Disclosures: Nothing to disclose.

Claudia R. Padilla, MD, Baylor Scott & White AT&T Memory Center
Disclosures: Nothing to disclose.

Jonathan H. Woodcock, MD, University of Colorado – Anschutz Medical Campus
Disclosures: Nothing to disclose.

Michael J. Schrift, DO, MA, FANPA, University of Washington Department of Psychiatry and Behavioral Science
Disclosures: Nothing to disclose.

Miles G. Cunningham, MD, McLean Hospital
Disclosures: Nothing to disclose.

Mary E. Quiceno, MD, University of North Texas Health Science Center
Disclosures: Serve as Appeals Advisory Panel member for NFL Concussion Injury Litigation/Settlement Program. Employed by Parexel as a Medical Director.


Staff Contact

Bryan Hagerla, Continuous Certification Manager
Disclosures: Nothing to disclose.
[email protected]
(612) 928-6326